James Bearden to Breast Neoplasms
This is a "connection" page, showing publications James Bearden has written about Breast Neoplasms.
Connection Strength
0.260
-
Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer. 2016 09; 24(9):3847-55.
Score: 0.070
-
A pilot randomized controlled trial testing a minimal intervention to prepare breast cancer survivors for recovery. Cancer Nurs. 2015 Mar-Apr; 38(2):E48-56.
Score: 0.065
-
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1460-6.
Score: 0.047
-
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol. 2008 Apr 01; 26(10):1650-6.
Score: 0.040
-
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007 May 20; 25(15):2093-9.
Score: 0.038